Preparation method and application of dual-network hydrogel surface

By introducing cell blots and aptamers into the hydrogels, the dual network hydrogels are formed, which solves the problem of low cancer cell capture ability in the prior art, and achieves efficient and stable cancer cell capture and culture, which is suitable for biology Medical Engineering.

CN119082034APending Publication Date: 2024-12-06LIAOCHENG PEOPLES HOSPITAL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411417171.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-08-11
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The biological materials used to capture cancer cells in the prior art have problems such as low capture ability, easy release and unstable structural structure, making it difficult to achieve efficient and stable cancer cell capture and culture.

Method used

Using the surface of a dual network hydrogel, a dual network hydrogel with micron-scale honeycomb structure and nanoparticles is formed by introducing cell blots and aptamers into the hydrogel, and combining multi-ring DNA aptamers to achieve cancer treatment. Efficient capture and culture of cells.

Benefits of technology

It has achieved efficient capture and culture of cancer cells, with stability and low degradation rate, and capture efficiency up to 93% or above, suitable for biomedical engineering applications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119082034A_ABST
    Figure CN119082034A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of biopolymer materials, in particular to a preparation method and application of a dual-network hydrogel surface. The dual-network hydrogel has a synergistic effect of cell imprinting and aptamer affinity, and can be accurately matched with the structure of a target cell, so that efficient capture and culture of a living target cell are realized; the stability is high, the degradation rate is low, and the adhesion, growth and multiplication capacities are good. The preparation method is high in universality and operability, and controllable preparation of the hydrogel can be achieved; the capture efficiency of the double-network hydrogel on MCF-7 and Hela cells is as high as 93 + / -3% and 90 + / -2% respectively, and the captured cancer cells still have high survivability on the surface of the hydrogel, so that the double-network hydrogel is expected to be applied to CTC culture and personalized test of drug sensitivity thereof, and has good development and application values.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] The application date of this invention is August 11, 2023, the application number is 202311010498.5, and the invention name is "A double network hydrogel surface and its preparation method and application". Technical Field

[0002] The invention relates to the technical field of biopolymer materials, and in particular to a preparation method and application of a double network hydrogel surface. Background Art

[0003] Cancer, or malignant tumor, is a disease caused by the unlimited proliferation of cancer cells due to abnormal control of cell division and proliferation mechanisms. Cancer cells can infiltrate normal tissues around the tumor, or they can be transferred to other tissues in the body through the circulatory system and lymphatic system, causing the disease to get out of control. Circulating tumor cells (CTCs) released from the tumor and passing through the peripheral blood and lymphatic system are the cause of cancer metastasis. Accurately measuring the level of CTCs in peripheral blood can provide valuable tumor information, reduce false positive results and reduce invasiveness. Therefore, it is very important to capture cancer cells in a targeted manner.

[0004] In the current existing technology, various fine material surfaces have been created to effectively capture rare CTCs by utilizing the unique biophysical and biochemical properties of CTCs and the progress of nanotechnology. However, due to the use of antibody-based strategies or lack of selective physical methods, the currently disclosed biomaterials have problems such as low CTC capture ability, easy release after capture, easy degradation of biomaterials, and unstable structure. Therefore, it is of great development and application value to prepare a stable biomaterial with low degradation rate to achieve selective and efficient capture and cultivation of cancer cells. Summary of the invention

[0005] In order to solve the shortcomings and deficiencies of the prior art, the primary purpose of the present invention is to provide a method for preparing a double network hydrogel surface, which is stable, efficient, universal and highly repeatable.

[0006] The second object of the present invention is to provide an application of the above-mentioned double-network hydrogel surface, which can efficiently capture cancer cells, is widely used in biomedical engineering, and has good development and application value.

[0007] To achieve the above purpose, the technical solution adopted by the present invention is as follows: A double network hydrogel surface, wherein the structure of the double network hydrogel surface is a micrometer-level honeycomb structure with a pore size of 21-32 μm; the double network hydrogel surface is composed of nanoparticles with a size of 400 nm-760 nm; and the double network hydrogel surface has a synergistic effect of cell imprinting and aptamer affinity.

[0008] Furthermore, the aptamer is a polycyclic DNA.

[0009] A method for preparing the above-mentioned double network hydrogel surface, the preparation method adopts the following steps: (1) Preparation of cell templates: Cultivate cancer cells, wash them, and use cell fixative to fix the cells on a culture dish to obtain a cell template; (2) Dissolving the monomer, polymer and initiator in deionized water, uniformly dropping the mixed solution onto the cell template prepared in step (1), and reacting at 60° C. for 2 h to form a composite hydrogel; peeling the composite hydrogel from the template, treating it with trypsin, and washing it; placing the treated hydrogel in a calcium chloride solution for cross-linking reaction, and washing to obtain a hydrogel template with cell imprint.

[0010] (3) Immerse the cell-imprinted hydrogel template prepared in step (2) in a poly-lysine solution for 2 hours to ensure that the template surface is fully modified, and thoroughly wash the template to remove unbound poly-lysine; transfer the washed template to a mixture of sulfo-NHS and EDC, soak it and wash it again to promote the cross-linking reaction and remove residual chemical reagents; use CMD solution to evenly cover the cell-imprinted surface of the template to further stabilize the imprinted structure; wash it to obtain a hydrogel surface with a double network.

[0011] Furthermore, in step (1), the density of the cultured cancer cells is 70-90%.

[0012] Furthermore, in step (2), the monomer is acrylamide (AM), acrylic acid (AA), cellulose, ethylene oxide (EO), methyl methacrylate (MMA), ethylene glycol dimethacrylate (EGDMA), propane or antimony trioxide; the polymer is polypropylene (PP), chitosan (CS), polycarbonate (PC), polyamide (PA), polyvinyl alcohol (PVA) or polyethylene glycol (PEG); the initiator is one or more of ammonium persulfate (APS), N,N,N',N'-tetramethylethylenediamine (TEMED) and hydrogen peroxide (H2O2); and the mass ratio of the compound monomer, polymer and initiator is 1.8:(0.5-0.75):0.0312.

[0013] Furthermore, in step (2), the concentration of the calcium chloride solution is 0.5-1 mol / L, and the cross-linking reaction time is 0.5-1 h.

[0014] Furthermore, in step (3), the polymer containing amino or carboxyl functional groups is polyaspartic acid (PASP), collagen protein, phosphoprotein, plasma protein, poly-D-lysine (Poly-D-lysine) or casein; and the polymerization reaction is carried out in a deoxygenated or vacuum environment at a temperature of 65-75°C and a time of 0.5-2h.

[0015] Furthermore, in step (3), the concentration of the CMD solution is 5-10 μg / mL, and the time for the aptamer solution to cover the cell imprint surface is 0.5-1h; the concentration ratio of sulfo-NHS to EDC in the sulfo-NHS / EDC mixture is 1:(2-3), wherein the concentration of sulfo-NHS is 1 mg / mL; the time for immersion in the sulfo-NHS / EDC mixture is 1-2h; the washing in steps (1), (2) and (3) are all performed using PBS; the concentration of trypsin in step (2) is 0.25% trypsin treatment; and the fixative in step (1) is 4% paraformaldehyde (PFA), 70% ethanol or 10% formalin.

[0016] Furthermore, the cancer cells in step (1) are breast cancer cells (MCF-7), cervical cancer cells (Hela), gastric cancer cells, colorectal cancer cells, lung cancer cells or liver cancer cells.

[0017] An application of the double-network hydrogel surface as described above, wherein the hydrogel surface can be applied to CTC culture.

[0018] Furthermore, the hydrogel surface can be applied to compare gene expression profiles of primary tumors, CTCs and metastatic lesions, or to study the expression of different surface markers of CTCs, or to test drug sensitivity of CTC culture.

[0019] Beneficial effects: (1) The present invention provides a double network hydrogel surface with synergistic effects of cell imprinting and aptamer affinity. By introducing cell imprinting into the hydrogel, the structure of cancer cells can be accurately matched; by introducing aptamers into the hydrogel, cancer cells can be targeted; the double network (DN) hydrogel contains a typical micron-scale honeycomb structure with a pore size of 21-32 μm, which makes it more stable and has a lower degradation rate; and the double network hydrogel is composed of nanoparticles with a size of 400-760 nm. The unique structural composition enables it to accurately match target cells, thereby achieving efficient capture and cultivation of cells.

[0020] (2) The preparation method of the double network hydrogel surface provided by the present invention is stable, efficient and highly repeatable; in addition, the preparation method provided by the present invention has the characteristics of universality and strong operability. By rationally regulating the composition of the compounds, the double network hydrogel can be modified to have cell imprinting and aptamer affinity, thereby realizing controllable preparation of the method.

[0021] (3) The double-network hydrogel surface provided by the present invention has good adhesion, growth and proliferation capabilities, and can efficiently capture cancer cells. The capture efficiency of MCF-7 and Hela cells is as high as 93±3% and 90±2%, respectively. In addition, the captured cancer cells still have a high survival ability on the hydrogel surface. It is widely used in biomedical engineering and has good development and application value. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] Figure 1 Schematic diagram of the process for preparing double-network hydrogel surfaces with cell imprinting and aptamers.

[0023] Figure 2 It is the SEM picture of comparative example 1-3 and embodiment 1-2; Figure 2 a and Figure 2 a1 is the SEM image of comparative example 2, Figure 2 b and Figure 2 b1 is the SEM image of comparative example 1, Figure 2 c and Figure 2 c1 is the SEM image of Example 1, Figure 2 d and Figure 2 d1 is the SEM image of Example 2, Figure 2 e and Figure 2 e1 is the SEM image of Comparative Example 3; Figure 3 is the UV spectrum of the double network hydrogel surface modified with different contents of aptamers prepared in Example 1; Figure 4 is the Hoechst staining image of cells in Example 1; Figure 4 a is the Hoechst staining image before cell removal. Figure 4 b is the composite image before cell removal, Figure 4 c is the Hoechst staining image before cell removal. Figure 4 d is the composite image after cell removal; Figure 5 It is a statistical diagram of the swelling rate and degradation rate of Comparative Example 1 and Examples 1-2; Figure 4 a is a statistical diagram of the swelling ratios of Example 1 and Examples 1-2, Figure 4 b is a statistical graph of degradation rates of Comparative Example 1 and Examples 1-2; Figure 6is a statistical diagram of the capture efficiency of the double network hydrogel surface prepared in Example 2 for cancer cells at different incubation times; Figure 7 It is a statistical graph of cancer cell capture efficiency and cancer cell proliferation quantity; Figure 7 a is a statistical diagram of cancer cell capture efficiency of comparative example 1-2 and embodiment 1-2, Figure 7 b is a statistical diagram of the number of cancer cell proliferations in Comparative Example 2 and Example 2; Figure 8 These are the microscope pictures and SEM pictures of cancer cell adhesion in Comparative Example 2 and Example 2; Figure 8 a1. Figure 8 a2 and Figure 8 a3 are the microscopic images of ECA-109, Hela and MCF-7 growing on ordinary culture dishes. Figure 8 b1. Figure 8 b2 and Figure 8 b3 are the microscopic images of the growth states of ECA-109, Hela and MCF-7 on the surface of Comparative Example 2, Figure 8 c1. Figure 8 c2 and Figure 8 c3 are the microscopic images of the growth states of ECA-109, Hela and MCF-7 on the surface of Example 2, Figure 8 d1, Figure 8 d2 and Figure 8 d3 are SEM images of the growth states of ECA-109, Hela and MCF-7 on the surface of Example 2; Fig. 9 This is a schematic diagram of the construction principle of polycyclic DNA aptamer (CMD). DETAILED DESCRIPTION

[0024] In order to further describe the present invention in detail, the following specific implementation examples are given, but they are only used to illustrate the present invention and make the steps clearer, rather than to limit the scope of application of the present invention.

[0025] Preparation method of polycyclic DNA (CMD): 1. Preparation of circular DNA ( C DNA), the nucleotide and primer sequences required for preparation are shown in Table 1: PD-L1 aptamer and PD-L1 aptamer primer were mixed in equal molar amounts, heated at 95°C for 3 min, and then slowly cooled to room temperature for 1 h. After adding 10×T4 DNA ligase buffer and 5 μL T4 DNA ligase to the mixture, the ligation reaction was initiated and the mixture was incubated at 16°C for 20 h. The linear DNA was circularized into a circular PD-L1 ( CPD-L1), prepared using the same method as above C DNA1 and C DNA2.

[0026] Table 1 2. Self-assembled polycyclic DNA: The first step is product purification. First, place a 10% denaturing polyacrylamide gel in an electrophoresis tank and add preheated TBE buffer. C PD-L1, C DNA1 and C DNA2 samples were mixed with Loading Buffer and spotted separately, and electrophoresis was performed at 110V to allow DNA molecules to migrate in the gel. After electrophoresis, the gel was fixed with a fixative, rinsed, and stained for observation under UV light. C PD-L1, C DNA1 and C DNA2 band. Finally, find the target C PD-L1, C DNA1 and C The DNA2 band was cut and soaked in a saline solution. C PD-L1, C DNA1 and C DNA2 is dissolved and then purified by ethanol precipitation or centrifugal column method. C PD-L1, C DNA1 and C DNA2.

[0027] The second step is to C PD-L1, C DNA1, C DNA2 was mixed at 95°C in a volume ratio of 1:1:3 for 60 min, and finally allowed to stand at room temperature for 1 h before further purification by PAGE to obtain self-assembled polycyclic DNA (CMD); 3. RCA reaction: For the RCA reaction, 2 μL of 10 μmol CMD was mixed with 1 μL of 10 μmol primer, and then 1 μl of 5 U / μ Phi29 DNA polymerase, 2 μL Phi29 DNA polymerase buffer, 3 μL of 25 μmol dNTP, and 11 μL RNase-free water were added. The RCA mixture was then applied to an ABI veriti 96-well thermal cycler. The conditions used for amplification included incubation at 42°C for 1 hour. Finally, the product was heated at 65°C for 10 minutes to inactivate the Phi29 enzyme to obtain the amplified product of CMD.

[0028] The prepared polycyclic CMD was added into PBS solution to prepare a concentration of 5-10 μg / mL.

[0029] Comparative Example 1 (1) Preparation of cell template: MCF-7 cells were cultured in a 100 mm × 20 mm cell culture dish until the cell density reached 80%. The cells were washed three times with PBS to remove impurities and residual serum components in the culture medium. Then, the cells were fixed with 4% paraformaldehyde (PFA) at room temperature for 10 min to fix the cells on the culture dish. Subsequently, the cells were washed with PBS to remove PFA and placed in PBS to obtain a culture dish with a cell template for continued imprinting. (2) Preparation of cell-imprinted hydrogel surface: 1.8 g AM, 0.03 g APS and 120 µL 10 mg ml - 1 TEMED was added to 10 mL of pure water, and the mixture was heated to 60°C and vibrated on an oscillator for 20 min to form a transparent solution. Subsequently, 120 µL of MBAA was added and mixed well. The mixture was quickly transferred to a culture dish with a cell template and heated at 70°C for 2 h to obtain a PAM hydrogel. The PAM hydrogel was peeled off and immersed in PBS until it expanded to the maximum level. In order to remove unreacted monomers and exhaust the cell template, the hydrogel was washed with PBS and reacted with 0.25% trypsin solution at 37°C. After the cells were completely removed, PBS and cell culture medium were used instead of trypsin solution for washing and cut into 24 mm 2 A circular-shaped hydrogel template with cell imprints; (3) Preparation of PAM hydrogel (CMD-CIDH1) surface with cell imprints and aptamers: The circular hydrogel template with cell imprints in step (2) was immersed in a 0.1 mg / mL poly-D-lysine solution for 12 h, and then the poly-D-lysine-modified cell imprints were immersed in a solution containing a mixture of 1 mg / mL sulfo-NHS and 2 mg / mL EDC for 2 h, washed twice with PBS solution, and then covered with 10 μg / mL of the polycyclic DNA aptamer (CMD) solution prepared above, left for 1 h, and washed twice with PBS solution to obtain the CMD-CIDH1 surface. The molar ratio of poly-D-lysine to CMD was 0.6.

[0030] Figure 2(b and b1) are SEM images of CMD-CIDH1. It can be seen from the figures that CMD-CIDH1 has a typical honeycomb structure and nanoparticles (NPs), where the pore size of CMD-CIDH1 is 40 μm and the size of the nanoparticles is 1300 nm.

[0031] Comparative Example 2 (1) Preparation of cell-free DN hydrogel surface: 1.8 g AM, 0.75 g short-chain CS (90% deacetylation), 0.03 g APS and 120 µL 10 mg mL -1 TEMED was added to 10 mL of pure water, and the mixture was heated to 60°C and vibrated on an oscillator for about 20 min to form a transparent solvent. After the mixture was deoxygenated, 120 µL of MBAA was added, and after mixing, the mixture was quickly transferred to a culture dish and heated at 70°C for 2 h to obtain a PAM-CS composite hydrogel. The composite hydrogel was immersed in a 1 M CaCl2 solution for 20 min. After standing for 5 h, a uniform PAM-CS DN hydrogel without a cell template was obtained. The DN hydrogel was peeled off and immersed in PBS until it swelled to the maximum level. In order to remove unreacted monomers and exhaust cell templates, the hydrogel was washed with PBS and incubated with 0.25% trypsin solution at 37°C. After the cells were completely removed, PBS and cell culture medium were used instead of trypsin solution for washing and cut into 24 mm 2 A circular-shaped hydrogel template with cell imprints; (2) Preparation of DN hydrogel (CMD-NCIDH) surface with aptamer: The preparation process is the same as that of Comparative Example 1.

[0032] Figure 2 (a and a1) are SEM images of CMD-NCIDH. Figure 2 a and Figure 2 As can be seen from a1, CMD-NCIDH has a mesh structure with a smooth surface and no nanoparticles.

[0033] Comparative Example 3 (1) Preparation of cell template: the preparation process is the same as that of Comparative Example 1; (2) Preparation of cell-imprinted DN hydrogel surface: 1.8 g AM, 1.5 g short-chain CS (90% deacetylation), 0.03 g APS and 120 µL 10 mg mL -1TEMED was added to 10 mL of pure water; the mixture was heated to 60°C and vibrated on an oscillator for about 20 min to form a transparent solvent; after the mixture was deoxygenated, 120 µL of MBAA was added, and after mixing, the mixture was quickly transferred to the above-mentioned culture dish with the cell template and heated at 70°C for 2 h to obtain the PAM-CS composite hydrogel; the composite hydrogel was immersed in 1 M CaCl2 solution for 20 min, and after standing for 5 h, a uniform PAM-CS DN hydrogel with a cell template was obtained; the DN hydrogel was peeled off and immersed in PBS until it swelled to the maximum level. In order to remove unreacted monomers and exhaust the cell template, the hydrogel was washed with PBS and incubated with 0.25% trypsin solution at 37°C; after the cells were completely removed, PBS and cell culture medium were used instead of trypsin solution for washing, and cut into 24 mm 2 The circular shape; (3) Preparation of DN hydrogel (CMD-CIDH4) surface with cell imprinting and aptamer: The preparation process is the same as that of Comparative Example 1.

[0034] Figure 2 (e and e1) are SEM images of CMD-CIDH4. It can be seen from the images that the typical honeycomb structure of the hydrogel has been replaced by an irregular structure. In addition, the nanoparticles NPs disappeared and were replaced by a denser structure.

[0035] Example 1 (1) Preparation of cell template: the preparation process is the same as that of Comparative Example 1; (2) Preparation of cell-imprinted DN hydrogel surface: 1.8 g AM, 0.5 g short-chain CS (90% deacetylation), 0.03 g APS and 120 µL 10 mg mL -1 TEMED was added to 10 mL of pure water; the mixture was heated to 60°C and vibrated on an oscillator for about 20 min to form a transparent solvent; after the mixture was deoxygenated, 120 µL of MBAA was added, mixed and quickly transferred to the above-mentioned culture dish with cell templates and heated at 70°C for 2 h to obtain PAM-CS composite hydrogel; the composite hydrogel was immersed in 1 M CaCl2 solution for 20 min, and after standing for 5 h, a uniform PAM-CS DN hydrogel with cell templates was obtained; the DN hydrogel was peeled off and immersed in PBS until it swelled to the maximum level; in order to remove unreacted monomers and exhaust cell templates, the hydrogel was washed with PBS and reacted with 0.25% trypsin solution at 37°C; after the cells were completely removed, PBS and cell culture medium were used instead of trypsin solution for washing and cut into 24 mm 2 A circular-shaped hydrogel template with cell imprints; (3) Preparation of DN hydrogel surface with cell imprinting and aptamer (CMD-CIDH2): The preparation process is the same as that of Comparative Example 1; the molar ratios of poly-D-lysine to CMD were 0.6, 0.8 and 1.0 respectively. Figure 3 In addition, the data characterizations related to the rest of Example 1 are all the results when the molar ratio of poly-D-lysine to CMD is 0.6.

[0036] Figure 2 (c and c1) are SEM images of CMD-CIDH2. It can be seen from the figures that CMD-CIDH2 has a typical honeycomb structure and nanoparticles, where the pore size of CMD-CIDH2 is 32 μm and the size of the nanoparticles is 760 nm.

[0037] Figure 3 The UV spectra of the DN hydrogel surface modified with different contents of aptamers are shown. The peak appearing at 260 nm indicates that CMD has been successfully modified on the DN hydrogel surface. The different contents of aptamer modification lead to changes in peak shape and peak value.

[0038] Figure 4 The cell removal rate before and after the cell template preparation is shown, and the Hoechst staining image shows that the cell removal efficiency is 100%.

[0039] Example 2 (1) Preparation of cell template: the preparation process is the same as that of Comparative Example 1; (2) Preparation of cell-imprinted DN hydrogel surface: 1.8 g AM, 0.75 g short-chain CS (90% deacetylation), 0.03 g APS and 120 µL 10 mg mL -1 TEMED was added to 10 mL of pure water; the mixture was heated to 60°C and vibrated on an oscillator for about 20 min to form a transparent solvent; after the mixture was deoxygenated, 120 µL of MBAA was added, mixed and quickly transferred to the above-mentioned culture dish with cell templates and heated at 70°C for 2 h to obtain PAM-CS composite hydrogel; the composite hydrogel was immersed in 1 M CaCl2 solution for 20 min, and after standing for 5 h, a uniform PAM-CS DN hydrogel with cell templates was obtained; the DN hydrogel was peeled off and immersed in PBS until it swelled to the maximum level; in order to remove unreacted monomers and exhaust cell templates, the hydrogel was washed with PBS and reacted with 0.25% trypsin solution at 37°C; after the cells were completely removed, PBS and cell culture medium were used instead of trypsin solution for washing and cut into 24 mm 2 A circular-shaped hydrogel template with cell imprints; (3) Preparation of DN hydrogel (CMD-CIDH3) surface with cell imprinting and aptamer: The preparation process is the same as that of Comparative Example 1.

[0040] Figure 2 (d and d1) are SEM images of CMD-CIDH3. It can be seen from the figures that CMD-CIDH3 has a typical honeycomb structure and nanoparticles, where the pore size of CMD-CIDH3 is 21 μm and the size of the nanoparticles is 400 nm.

[0041] Performance Testing 1. Stability test Detection of hydrogel swelling rate and degradation rate (DR): After CMD-CIDH1-3 was placed in PBS solution at 37°C for 10 h, CMD-CIDH1-3 still showed good swelling properties. The CS in CMD-CIDH2-3 interacted with the polymer, increasing the crosslinking density of the hydrogel, thereby increasing the porosity of the hydrogel and reducing the swelling properties of the hydrogel to a certain extent.

[0042] CMD-CIDH1-3 was freeze-dried and the initial mass W0 of CMD-CIDH1-3 was recorded. Then, CMD-CIDH1-3 was placed in a PBS solution at 37°C and its swelling changes were observed. At 2 h, 6 h, 12 h, 24 h, 48 h and 72 h, filter paper was used to absorb the water on the surface of each example, and samples were taken and their weights W were recorded. i , when the weight no longer changes, expansion equilibrium is reached. Three samples are tested in each group.

[0043] The calculation formula of hydrogel swelling degree (W) is as follows: W=(W i - W0) / W0× 100% The results are as follows Figure 5 As shown by Figure 5 a It can be seen that the swelling rates of CMD-CIDH1-3 are 92%, 86% and 81%, respectively. This is because the pore size of CMD-CIDH1 is 40 μm, and the size of the nanoparticles is 1300 nm. The larger pore size and nanoparticle size make its swelling rate higher.

[0044] After freeze-drying CMD-CIDH1-3, its original mass M0 was recorded. Then, CMD-CIDH1-3 was placed in a 37°C PBS degradation solution and incubated under an ultraviolet lamp. The degradation solution was changed every day and the freeze-dried CMD-CIDH1-3 was weighed and its mass M0 was recorded. i Three samples were tested in each group.

[0045] The hydrogel degradation rate (DR) can be calculated by the following formula: DR=(M0-M i ) / M0×100% Depend on Figure 5 As can be seen in b, CMD-CIDH1 was completely degraded on the 12th day, and CMD-CIDH2-3 was completely degraded on the 14th day.

[0046] 2. Cell capture efficiency and proliferation test PD-L1-positive MCF-7 and Hela cells, as well as PD-L1-negative human esophageal cancer cell ECA-109, were selected to evaluate the sensitivity of CMD-CIDH3 surface as a target cell recognition. First, the capture efficiency of the above cells by CMD-CIDH3 surface was determined after different incubation times. Figure 6 The results showed that after 90 min of incubation, the capture efficiency of MCF-7 and Hela cells on the CMD-CIDH3 surface was significantly improved, reaching 93±3% and 90±2%, respectively, while the capture efficiency of PD-L1-negative ECA-109 cells was less than 7%. The results showed that the CMD-CIDH3 surface has high sensitivity and specificity in recognizing specific cell lines.

[0047] PD-L1 positive MCF-7 and Hela cells were selected to detect the capture efficiency of target cells by CMD-NCIDH and CMD-CIDH1-3 surfaces. The results are as follows Figure 7 As shown in Figure 2, the capture efficiency of MCF-7 and Hela cells on the CMD-CIDH2-3 surface is much higher than that on the CMD-NCIDH and CMD-CIDH1 surfaces ( Figure 7 a); Then the activity of the target cells captured on the surface of CMD-CIDH3 was detected, and further cultured and propagated. Figure 7 b shows that the number of MCF-7 cells captured on the CMD-CIDH3 surface proliferated similarly to that of untreated cells, increasing exponentially over time, and the slopes of the linear plots of their logarithms of proliferation were similar, 0.043 (R 2 =0.994) and 0.045 (R 2 =0.996), indicating that these cells still have a high viability.

[0048] 3. Cell Growth Status Test PD-L1-positive MCF-7 and Hela cells, as well as PD-L1-negative human esophageal cancer cell ECA-109, were selected to detect the growth status of different types of cancer cells captured by CMD-CIDH3. The results are as follows Figure 8 As shown, Figure 8 a shows the above ECA-109 ( Figure 8 a1), Hela ( Figure 8 a2) and MCF-7 ( Figure 8 a3) Growth status on ordinary culture dishes, Figure 8 b shows the above ECA-109 ( Figure 8 b1), Hela ( Figure 8 b2) and MCF-7 ( Figure 8 b3) Growth states on the CMD-NCIDH surface, respectively. Figure 8 c shows the above ECA-109 ( Figure 8 c1)、Hela( Figure 8 c2) and MCF-7 ( Figure 8 c3) Growth states on the CMD-CIDH3 surface, Figure 8 d is the above ECA-109 ( Figure 8 d1)、Hela( Figure 8 d2) and MCF-7 ( Figure 8 d3) SEM images of the growth states on the CMD-CIDH3 surface. The results show that the three cells are in a round state on the CMD-NCIDH surface and are not fully stretched. On the CMD-CIDH3 surface, the three cells have tail feet and are in a spreading state, which is the same as the spreading state of ordinary culture dishes. At the same time, the SEM images also verify that the three cells have good adhesion, growth and proliferation on the CMD-CIDH3 surface.

[0049] The above embodiments can partially demonstrate the content of the present invention, but the present invention is not limited to the monomers described in the embodiments, that is, the description of the above embodiments is not a limitation of the present invention. Those skilled in the art should understand that improvements to the present invention, equivalent replacement of raw materials of the products of the present invention, addition of auxiliary components, or direct or indirect application in other related technical fields should all be included in the scope of patent protection of the present invention.

Claims

1. A method for preparing a double network hydrogel surface, characterized in that: The preparation method adopts the following steps: (1) Preparation of cell templates: Cultivate cancer cells, wash them, and use cell fixative to fix the cells on a culture dish to obtain a cell template; (2) dissolving the monomer, polymer and initiator in deionized water, and uniformly dropping the mixed solution onto the cell template prepared in step (1) to react and form a composite hydrogel; peeling the composite hydrogel from the template, treating it with trypsin, and washing it; placing the treated composite hydrogel in a calcium chloride solution for cross-linking reaction, and washing it to obtain a hydrogel template with cell imprint. (3) immersing the cell-imprinted hydrogel template prepared in step (2) in a poly-lysine solution for 2 hours to wash the template; The washed template is transferred to a mixed solution of sulfo-NHS and EDC for immersion, washed again, and the polycyclic DNA solution is covered on the cell imprint surface of the template; After washing, a double-network hydrogel surface was obtained.

2. The preparation method according to claim 1, characterized in that: In step (1), the density of the cultured cancer cells is 70-90%.

3. The preparation method according to claim 1, characterized in that: In step (2), the monomer is acrylamide, acrylic acid, cellulose, ethylene oxide, methyl methacrylate, ethylene glycol dimethacrylate, propane or antimony trioxide; the polymer is polypropylene, chitosan, polycarbonate, polyamide, polyvinyl alcohol or polyethylene glycol; the initiator is one or more of ammonium persulfate, N,N,N',N'-tetramethylethylenediamine and hydrogen peroxide; the mass ratio of the compound monomer, polymer and initiator is 1.8:(0.5-0.75):0.0312.

4. The preparation method according to claim 1, characterized in that The concentration of the calcium chloride solution is 0.5-1 mol / L, and the cross-linking reaction time is 0.5-1 h.

5. The preparation method according to claim 1, characterized in that: In step (3), the polymer containing amino or carboxyl functional groups is poly-D-lysine, poly-aspartic acid, collagen, phosphoprotein, plasma protein, poly-D-lysine or casein.

6. The preparation method according to claim 1, characterized in that: In step (3), the polycyclic DNA solution is a PBS solution of polycyclic DNA with a concentration of 5-10 μg / mL, and the time for the polycyclic DNA solution to cover the cell imprint surface is 0.5-1h; the concentration ratio of sulfo-NHS to EDC in the sulfo-NHS / EDC mixture is 1:(2-3), wherein the concentration of sulfo-NHS is 1 mg / mL; the time for immersion in the sulfo-NHS / EDC mixture is 1-2h; and the washing in steps (1), (2), and (3) are all performed using PBS.

7. The preparation method according to claim 1, characterized in that: The cancer cells described in step (1) are breast cancer cells, cervical cancer cells, gastric cancer cells, colorectal cancer cells, lung cancer cells or liver cancer cells.

8. An application of a double network hydrogel surface prepared by the method according to any one of claims 1 to 7, characterized in that: The hydrogel surface is applied to CTC culture; preferably, the hydrogel surface can be applied to compare gene expression profiles of primary tumors, CTCs and metastases, or to study the expression of different surface markers of CTCs, or to test drug sensitivity of CTC culture.